UCSF Helen Diller Family Comprehensive Cancer Ctr

The overall cancer death rate is declining steadily in the US, and more individuals are living longer and fuller lives after a cancer diagnosis. Read about the research-driven progress during National Cancer Research Month—#NCRM25: brnw.ch/21wSpgz #UnitedByCancerResearch

May is National Cancer Research Month. Dr. LoRusso, AACR Past President, explains how basic research is essential to accelerating advances in cancer science and medicine. Learn more in the @AACR Cancer Progress Report: brnw.ch/21wSpYt #NCRM25 #UnitedByCancerResaerch

“The field as a whole, in the last 10 years, has gone incredibly fast to come up with innovative molecules to target KRAS” @kevansf @UCSF in #AACR25 Keynote | Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR ow.ly/UBT250VN3Z9 @aacr

Donʻt miss today, May 1st at 4pm: Maria Castro, PhD @castro2355_mg @umich presents "Epigenetic reprogramming of the immune microenvironment in H3G34R pediatric high-grade gliomas" at our Friday Seminar Series @UCSF ow.ly/6jh650VJkV5

We thank the more than 22,000 attendees—including more than 900 virtual attendees—from 81 countries who participated in the AACR Annual Meeting 2025 in Chicago. The #AACR25 hashtag garnered 636 million impressions from 3,852 users on X alone.

The 2024-2025 recipients of AACR grants presented their work in a special poster session this evening at #AACR25.

Congratulations to UCSF's Sophia Miliotis on taking home first place at the 2025 @UofCalifornia Grad Slam!

Successfully presented my research on Exarafenib at #AACR25 today. Grateful to the session chairs for their valuable feedback and support. Looking forward to the future of BRAF-targeted therapies in cancer! #CancerResearch #LungCancer #BRAF

Friday, May 1st at 4pm: Maria Castro, PhD @castro2355_mg @umich presents "Epigenetic reprogramming of the immune microenvironment in H3G34R pediatric high-grade gliomas" at our @UCSF Friday Seminar Series in Basic and Translational Research ow.ly/L7CP50VJkUw

Tues, April 30th 10:15 AM CT | @UCSF at #AACR25 | Xiaokun Shu, PhD, presents "New physical biology of oncoprotein condensates: Differential regulation of the transcriptome by phase separation" at @aacr. Session preview: ow.ly/wqrQ50VJkuC

Wednesday, April 30th 12:39 PM CT | @UCSF at #AACR25 | Plenary Session on meeting highlights and Vision for the Future. Scarlett Gomez, PhD, MPH @UCSF_Epibiostat will present. ow.ly/X2iq50VJk3Y

Catch the @BivonaLabUCSF team at #AACR25 on April 29th! @Tadashi_Manabe | 2:30–4:00 PM Minisymposium, Room S102 @YTChou | 2:00–5:00 PM Section 18, Board 19 Nilanjana Chatterjee | 2:00–5:00 PM Section 17, Board 5 We’ll be sharing our latest research @UCSFCancer

Kicking off the Frontiers in Computational Health Conference 2025! @UCBerkeley Vice Chancellor for Research, Kathy Yelick - Welcome by co-directors @Idasim @DrMayaPetersen @UCJointCPH @BerkeleyCTML computationalhealth.ucsf.edu/conference-age… @UCSF

Excited to share that our work was published in @JCO_ASCO! A report from the @COGorg: stem cell transplantation is associated with improved outcomes for children diagnosed with high-risk acute myeloid leukemia (AML). ascopubs.org/doi/10.1200/JC…

🚨🧬Everything you wanted to know about actionable #neoantigens resulting from cancer mutations besides point mutations (*but were afraid to ask). Join us at 10:15 in 📍Room E351 - McCormick Lakeside Center (Level 3)! @MSKCancerCenter @UCSFCancer @institut_curie

At the #AACR25 plenary, Matthew Krummel, PhD, (@UCSFCancer) explores therapeutic strategies to reshape the tumor micro- and macroenvironment, including 12 tumor immune archetypes that may help uncover novel targeted treatments. Read more: abstractsonline.com/pp8/#!/20273/p… #MoffittAACR25…

UCSF neurosurgery experts including Drs. Shawn @HerveyJumper, @robcosorio, Praveen Mummaneni & Dr. Nima Alan presented new research & clinical findings at the prestigious @AANSNeuro Annual Scientific Meeting in Boston. #AANS2025 Details on their talks ➡️ ucsfh.org/3YjF3UW

Check out our podium at #AUA25 tomorrow discussing upstream regulators of STEAP1 in prostate cancer, presented by Dr. Sasha Zhu @UCSFUrology @UCSFCancer auajournals.org/doi/10.1097/01…

Excited to present my research on Exarafenib at #AACR25 tomorrow. My work demonstrates promising efficacy against all classes of BRAF mutations in NSCLC, especially Class 2/3 that lack treatment options. #CancerResearch #BRAF #LungCancer

Tuesday, April 29th 10:45 AM CT | @UCSF at #AACR25 | Major Symposium: Immunology with Hideho Okada, MD, PhD presenting "Tumor-wide RNA splicing aberrations generate therapeutically actionable public neoantigens" at ow.ly/LgEG50VJjWP @aacr